GlassScriptPhysician profile
John L Burzotta
NPI 1417069634
$725.93
in general payments reported to CMS, 2019-2025
15 companies · $15.64 in 2025
The $15.64 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $90.99 · 2020: $30.06 · 2021: $271 · 2022: $132 · 2023: $115 · 2024: $71.09 · 2025: $15.64.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $201.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $201.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Djo, LLC | $139.72 | 2021 | |
| Gramercy Extremity Orthopedics LLC | $114.66 | 2023 | |
| Sebela Pharmaceuticals INC. | $72.50 | 2019-2020 | |
| Abbvie INC. | $65.65 | 2021-2022 | |
| Stryker Corporation | $47.93 | 2021-2024 | Prostep Mica |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $46.93 | 2022 | |
| Next Science LLC | $45.82 | 2024 | Surgx, Xperience, Blastx |
| Zimmer Biomet Holdings, INC. | $38.43 | 2022 | |
| In2bones USA, LLC | $33.95 | 2021 | |
| Tactile Systems Technology INC | $30.21 | 2019 | |
| Horizon Therapeutics Plc | $22.53 | 2021 | |
| Advanced Oxygen Therapy INC. | $20.25 | 2021 | |
| Wright Medical Technology, INC. | $18.34 | 2019 | |
| Biocomposites INC | $15.64 | 2025 | Stimulan |
| Alfasigma USA, INC. | $13.37 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Burzotta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.